Understanding Gene Therapy & CRISPR/Cas9: Upcoming Clinical DMD Symposium

Last month, PPMD welcomed Dr. Eric Olson from UT Southwestern Medical Center to discuss the basics of gene editing and the potential permanent correction of Duchenne mutations with CRISPR/Cas9. If you missed it live, check out the recording to learn more about this technology and what it could mean for Duchenne.

Continuing the conversation, UT Southwestern will be hosting a Clinical DMD Symposium on Friday, August 26 from 9.30-3.30pm, to update Duchenne patients and their families on the role of genome editing as a potential therapy for Duchenne, as well as provide an update on the standard of care for management of Duchenne.

Clinical DMD Symposium Details:

• Streaming instructions
• Meeting agenda